ZBP1 mediates interferon-induced necroptosis.
Animals
Caspase 8
/ metabolism
Cell Line
Fas-Associated Death Domain Protein
/ metabolism
Humans
Interferons
/ pharmacology
Janus Kinase 1
/ metabolism
Male
Mice, Inbred C57BL
Mice, Knockout
Mutant Proteins
/ metabolism
Necroptosis
/ drug effects
Protein Binding
/ drug effects
Protein Biosynthesis
/ drug effects
Protein Domains
RNA-Binding Proteins
/ chemistry
Receptor-Interacting Protein Serine-Threonine Kinases
/ metabolism
STAT1 Transcription Factor
/ metabolism
Signal Transduction
/ drug effects
Systemic Inflammatory Response Syndrome
/ metabolism
Tumor Necrosis Factor-alpha
ZBP1
interferon
necroptosis
Journal
Cellular & molecular immunology
ISSN: 2042-0226
Titre abrégé: Cell Mol Immunol
Pays: China
ID NLM: 101242872
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
13
01
2019
accepted:
21
04
2019
pubmed:
12
5
2019
medline:
4
6
2021
entrez:
12
5
2019
Statut:
ppublish
Résumé
Interferons (IFNs) play an important role in immunomodulatory and antiviral functions. IFN-induced necroptosis has been reported in cells deficient in receptor-interacting protein kinase 1 (RIPK1), Fas-associated protein with death domain (FADD), or caspase-8, but the mechanism is largely unknown. Here, we report that the DNA-dependent activator of IFN regulatory factors (ZBP1, also known as DAI) is required for both type I (β) and type II (γ) IFN-induced necroptosis. We show that L929 fibroblast cells became susceptible to IFN-induced necroptosis when RIPK1, FADD, or Caspase-8 was genetically deleted, confirming the antinecroptotic role of these proteins in IFN signaling. We found that the pronecroptotic signal from IFN stimulation depends on new protein synthesis and identified ZBP1, an IFN-stimulated gene (ISG) product, as the de novo synthesized protein that triggers necroptosis in IFN-stimulated cells. The N-terminal domain (ND) of ZBP1 is important for ZBP1-ZBP1 homointeraction, and its RHIM domain in the C-terminal region interacts with RIPK3 to initiate RIPK3-dependent necroptosis. The antinecroptotic function of RIPK1, FADD, and caspase-8 in IFN-treated cells is most likely executed by caspase-8-mediated cleavage of RIPK3, since the inhibitory effect on necroptosis was eliminated when the caspase-8 cleavage site in RIPK3 was mutated. ZBP1-mediated necroptosis in IFN-treated cells is likely physiologically relevant, as ZBP1 KO mice were significantly protected against acute systemic inflammatory response syndrome (SIRS) induced by TNF + IFN-γ.
Identifiants
pubmed: 31076724
doi: 10.1038/s41423-019-0237-x
pii: 10.1038/s41423-019-0237-x
pmc: PMC7109092
doi:
Substances chimiques
Fadd protein, mouse
0
Fas-Associated Death Domain Protein
0
Mutant Proteins
0
RNA-Binding Proteins
0
STAT1 Transcription Factor
0
Tumor Necrosis Factor-alpha
0
Zbp1 protein, mouse
0
Interferons
9008-11-1
Janus Kinase 1
EC 2.7.10.2
Receptor-Interacting Protein Serine-Threonine Kinases
EC 2.7.11.1
Ripk1 protein, mouse
EC 2.7.11.1
Caspase 8
EC 3.4.22.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
356-368Références
Vilcek, J. Fifty years of interferon research: aiming at a moving target. Immunity 25, 343–8 (2006).
pubmed: 16979566
doi: 10.1016/j.immuni.2006.08.008
Honda, K., Takaoka, A. & Taniguchi, T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25, 349–60 (2006).
pubmed: 16979567
doi: 10.1016/j.immuni.2006.08.009
Pestka, S., Krause, C. D. & Walter, M. R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202, 8–32 (2004).
pubmed: 15546383
doi: 10.1111/j.0105-2896.2004.00204.x
van Boxel-Dezaire, A. H., Rani, M. R. & Stark, G. R. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25, 361–72 (2006).
pubmed: 16979568
doi: 10.1016/j.immuni.2006.08.014
Piehler, J., Thomas, C., Garcia, K. C. & Schreiber, G. Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. Immunol. Rev. 250, 317–34 (2012).
pubmed: 23046138
pmcid: 3986811
doi: 10.1111/imr.12001
Marcello, T. et al. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131, 1887–98 (2006).
pubmed: 17087946
doi: 10.1053/j.gastro.2006.09.052
Schindler, C., Levy, D. E. & Decker, T. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282, 20059–63 (2007).
pubmed: 17502367
doi: 10.1074/jbc.R700016200
Bach, E. A., Aguet, M. & Schreiber, R. D. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15, 563–91 (1997).
pubmed: 9143700
doi: 10.1146/annurev.immunol.15.1.563
Dussurget, O., Bierne, H. & Cossart, P. The bacterial pathogen Listeria monocytogenes and the interferon family: type I, type II and type III interferons. Front. Cell. Infect. Microbiol. 4, 50 (2014).
pubmed: 24809023
pmcid: 4009421
doi: 10.3389/fcimb.2014.00050
Thapa, R. J. et al. NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis. Mol. Cell. Biol. 31, 2934–46 (2011).
pubmed: 21576359
pmcid: 3133390
doi: 10.1128/MCB.05445-11
Dillon, C. P. et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157, 1189–202 (2014).
pubmed: 24813850
pmcid: 4068710
doi: 10.1016/j.cell.2014.04.018
Thapa, R. J. et al. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc. Natl Acad. Sci. USA 110, E3109–E18 (2013).
pubmed: 23898178
doi: 10.1073/pnas.1301218110
pmcid: 3746924
McComb, S. et al. Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages. Proc. Natl Acad. Sci. USA 111, E3206–E13 (2014).
pubmed: 25049377
pmcid: 4128105
Fu, Y. et al. Cloning of DLM-1, a novel gene that is up-regulated in activated macrophages, using RNA differential display. Gene 240, 157–63 (1999).
pubmed: 10564822
doi: 10.1016/S0378-1119(99)00419-9
Takaoka, A. et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448, 501–U14 (2007).
pubmed: 17618271
doi: 10.1038/nature06013
Ishii, K. J. et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451, 725–9 (2008).
pubmed: 18256672
doi: 10.1038/nature06537
Upton, J. W., Kaiser, W. J. & Mocarski, E. S. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11, 290–7 (2012).
pubmed: 22423968
pmcid: 3531981
doi: 10.1016/j.chom.2012.01.016
Sridharan, H. et al. Murine cytomegalovirus IE3-dependent transcription is required for DAI/ZBP1-mediated necroptosis. EMBO Rep. 18, 1429–41 (2017).
pubmed: 28607035
pmcid: 5538628
doi: 10.15252/embr.201743947
Maelfait, J. et al. Sensing of viral and endogenous RNA by ZBP1/DAI induces necroptosis. EMBO J. 36, 2529–43 (2017).
pubmed: 28716805
pmcid: 5579359
doi: 10.15252/embj.201796476
Thapa, R. J. et al. DAI senses influenza A virus genomic RNA and activates RIPK3-dependent cell death. Cell Host Microbe 20, 674–81 (2016).
pubmed: 27746097
pmcid: 5687825
doi: 10.1016/j.chom.2016.09.014
Koehler, H. et al. Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3. Proc. Natl Acad. Sci. USA 114, 11506–11 (2017).
pubmed: 29073079
doi: 10.1073/pnas.1700999114
pmcid: 5664489
Chen, D. et al. PUMA amplifies necroptosis signaling by activating cytosolic DNA sensors. Proc. Natl Acad. Sci. USA 115, 3930–5 (2018).
pubmed: 29581256
doi: 10.1073/pnas.1717190115
pmcid: 5899441
Kuriakose, T. et al. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci. Immunol. 1, 2 (2016).
doi: 10.1126/sciimmunol.aag2045
Newton, K. et al. RIPK1 inhibits ZBP1-driven necroptosis during development. Nature 540, 129-+ (2016).
pubmed: 27819682
doi: 10.1038/nature20559
Lin, J. et al. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. Nature 540, 124–8 (2016).
doi: 10.1038/nature20558
Feng, S. et al. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell. Signal. 19, 2056–67 (2007).
pubmed: 17644308
doi: 10.1016/j.cellsig.2007.05.016
Lin, Y., Devin, A., Rodriguez, Y. & Liu, Z. G. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 13, 2514–26 (1999).
pubmed: 10521396
pmcid: 317073
doi: 10.1101/gad.13.19.2514
Wang, L., Du, F. & Wang, X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133, 693–703 (2008).
pubmed: 18485876
doi: 10.1016/j.cell.2008.03.036
Kaiser, W. J. et al. RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc. Natl Acad. Sci. USA 111, 7753–8 (2014).
pubmed: 24821786
doi: 10.1073/pnas.1401857111
pmcid: 4040608
Rickard, J. A. et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157, 1175–88 (2014).
pubmed: 24813849
doi: 10.1016/j.cell.2014.04.019
Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213–27 (2012).
pubmed: 22265413
doi: 10.1016/j.cell.2011.11.031
Cho, Y. S. et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112–23 (2009).
pubmed: 19524513
pmcid: 2727676
doi: 10.1016/j.cell.2009.05.037
He, S. et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137, 1100–11 (2009).
pubmed: 19524512
doi: 10.1016/j.cell.2009.05.021
Zhang, D. W. et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332–6 (2009).
pubmed: 19498109
doi: 10.1126/science.1172308
Chen, W. et al. Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling. J. Biol. Chem. 288, 16247–61 (2013).
pubmed: 23612963
pmcid: 3675564
doi: 10.1074/jbc.M112.435545
Huang, Z. et al. RIP1/RIP3 binding to HSV-1 ICP6 initiates necroptosis to restrict virus propagation in mice. Cell Host Microbe 17, 229–42 (2015).
pubmed: 25674982
doi: 10.1016/j.chom.2015.01.002
Upton, J. W., Kaiser, W. J. & Mocarski, E. S. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11, 290–7 (2012).
pubmed: 22423968
pmcid: 3531981
doi: 10.1016/j.chom.2012.01.016
Rebsamen, M. et al. DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappa B. EMBO Rep. 10, 916–22 (2009).
pubmed: 19590578
pmcid: 2726668
doi: 10.1038/embor.2009.109
Kaiser, W. J., Upton, J. W. & Mocarski, E. S. Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors. J. Immunol. 181, 6427–34 (2008).
pubmed: 18941233
doi: 10.4049/jimmunol.181.9.6427
Wu, X. N. et al. Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis. Cell Death Differ. 21, 1709–20 (2014).
pubmed: 24902902
pmcid: 4211369
doi: 10.1038/cdd.2014.77
Chen, X. et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res. 24, 105–21 (2014).
pubmed: 24366341
doi: 10.1038/cr.2013.171
Kelliher, M. A. et al. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8, 297–303 (1998).
pubmed: 9529147
doi: 10.1016/S1074-7613(00)80535-X
Ting, A. T., Pimentel-Muinos, F. X. & Seed, B. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J. 15, 6189–96 (1996).
pubmed: 8947041
pmcid: 452440
doi: 10.1002/j.1460-2075.1996.tb01007.x
Duprez, L. et al. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 35, 908–18 (2011).
pubmed: 22195746
doi: 10.1016/j.immuni.2011.09.020
Tracey, K. J. et al. Shock and tissue injury induced by recombinant human cachectin. Science 234, 470–4 (1986).
pubmed: 3764421
doi: 10.1126/science.3764421
Huys, L. et al. Type I interferon drives tumor necrosis factor-induced lethal shock. J. Exp. Med. 206, 1873–82 (2009).
pubmed: 19687227
pmcid: 2737160
doi: 10.1084/jem.20090213
Vanlangenakker, N., Vanden Berghe, T. & Vandenabeele, P. Many stimuli pull the necrotic trigger, an overview. Cell Death Differ. 19, 75–86 (2012).
pubmed: 22075985
doi: 10.1038/cdd.2011.164
Pasparakis, M. & Vandenabeele, P. Necroptosis and its role in inflammation. Nature 517, 311–20 (2015).
doi: 10.1038/nature14191
pubmed: 25592536
Berger, S. B. et al. Cutting edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J. Immunol. 192, 5476–80 (2014).
pubmed: 24821972
doi: 10.4049/jimmunol.1400499
Polykratis, A. et al. Cutting edge: RIPK1 kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo. J. Immunol. 193, 1539–43 (2014).
pubmed: 25015821
doi: 10.4049/jimmunol.1400590
Dannappel, M. et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513, 90–4 (2014).
doi: 10.1038/nature13608
Takahashi, N. et al. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature 513, 95–9 (2014).
pubmed: 25186904
doi: 10.1038/nature13706
Ofengeim, D. et al. Activation of necroptosis in multiple sclerosis. Cell Rep. 10, 1836–49 (2015).
pubmed: 25801023
pmcid: 4494996
doi: 10.1016/j.celrep.2015.02.051
Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929–47 (2014).
pubmed: 25186741
pmcid: 4152602
doi: 10.1523/JNEUROSCI.1860-14.2014
Chen, W. Z. et al. Ppm1b negatively regulates necroptosis through dephosphorylating Rip3. Nat. Cell Biol. 17, 434–44 (2015).
doi: 10.1038/ncb3120
Chen, W. Z. et al. Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling. J. Biol. Chem. 288, 16247–61 (2013).
pubmed: 23612963
pmcid: 3675564
doi: 10.1074/jbc.M112.435545